• Potential Risks and Benefits for Using Nsaids in The Treatment of Rheumatoid Arthritis

    May 1, 2018, 00:00

  • The Comparison of China EQ-5D-3L and EQ-5D-5L Value Sets Applied in General Population

    May 1, 2018, 00:00

  • Assessing Drug Price Changes Over 1 Year and their Influence on Budget Impact

    May 1, 2018, 00:00

  • Delphi Method- A Qualitative Approach For Quantitative Results

    May 1, 2018, 00:00

  • Prescription Opioid Use Among Children and Adolescents with Asthma in the United States- National Estimates from 2011 to 2015

    May 1, 2018, 00:00

  • A Real-World Assessment of the Clinical and Economic Impact of Powered Vs Manual Endoscopic Staplers when Used in Conjunction with Buttress in Bariatric Surgery

    May 1, 2018, 00:00

  • Estimating the Effects of Extended-Release Formulations on Adherence, HBA1C Control and Hospital Outcomes

    May 1, 2018, 00:00

  • National Trends in Utilization of Bariatric Surgery

    May 1, 2018, 00:00

  • Costs and Trends in the Usage of Biological Therapy for Rheumatoid Arthritis - A Retrospective Study

    May 1, 2018, 00:00

  • Real-World Out-Of-Pocket Expenses (OPE) Among Advanced (Stage IIIB/C And IV) Breast Cancer (ABC) Patients Undergoing Treatment in the United States (US)

    May 1, 2018, 00:00

  • An Empirical Evaluation of Pharmacy “Gag” Rules in the US

    May 1, 2018, 00:00

  • Perspectives Of Quality Risk Management Application In Economical Evaluations Alongside Clinical Trials

    May 1, 2018, 00:00

  • Comparative Analysis Investigating the Impact of Implant Design on Hospital Length of Stay and Discharge Destination in a Dutch Hospital with an Established Enhanced Recovery Program

    May 1, 2018, 00:00

  • Evidence-Based Valuation- A Novel Framework for Drug Pricing

    May 1, 2018, 00:00

  • Contemporary Natural History Of Heart Failure In Nova Scotia, Canada

    May 1, 2018, 00:00

  • The Impact of Nutrition-Focused Quality Improvement Interventions on Length of Stay and Readmission Rates Among Hospitalized Malnourished Patients

    May 1, 2018, 00:00

  • Clopidogrel Versus Aspirin For The Treatment Of Acute Coronary Syndrome After A 12-Month Dual Antiplatelet Therapy- A Cost-Effectiveness Analysis From China Payer’s Perspective

    May 1, 2018, 00:00

  • Using Electronic Health Records to Examine HPV Vaccine Initiation and Completion Rates

    May 1, 2018, 00:00

  • Treatment Patterns and Healthcare Resource Utilization Among Young Adults with Schizophrenia Treated with Paliperidone Palmitate or Oral Atypical Antipsychotics

    May 1, 2018, 00:00

  • Daily Reports of Pain are Associated with Duration and Quality of Sleep in African American Older Adults

    May 1, 2018, 00:00

  • US Lupus Trends 2009-2017- Results from the National Health and Wellness Survey

    May 1, 2018, 00:00

  • Effectiveness of Primary Treatment for Elderly than 75 Years with Prostate Cancer- Korean National Health Insurance Database

    May 1, 2018, 00:00

  • A Canadian Cost-Utility Analysis of two Trabecular Micro-Bypass Stents in Patients with Mild-to-Moderate Open-Angle Glaucoma

    May 1, 2018, 00:00

  • Framework for Systematic Review of Cost and Resource Use Studies

    May 1, 2018, 00:00

  • Cost-Effectiveness Analysis of High-Sensitivity Troponin T Versus Conventional Troponin I Testing for Acute Myocardial Infarction

    May 1, 2018, 00:00

  • A Systematic Assessment of Budget Impact Models for Medical Devices

    May 1, 2018, 00:00

  • Differences in Risks of Synchronous and Metachronous Second Primary Cancers Among Head and Neck Cancer Patients

    May 1, 2018, 00:00

  • Economic Outcomes of Medicare Reimbursement Policy Change on Erythropoiesis-Stimulating Agents in Cancer Patients

    May 1, 2018, 00:00

  • Assessing Readiness of US Community Rheumatologists for Implementation of Medicare Access and Chip Reauthorization act (MACRA), Merit-Based Incentive Payment System (MIPS) and Alternative Payment Models (APMS)

    May 1, 2018, 00:00

  • Modified Drug Adherence Work-Up (M-DRAW) Tool in Patients With Diabetes at Veterans Affairs Health System- Tool Validation And Preliminary Result

    May 1, 2018, 00:00

  • Off Label Use of Proton Pump Inhibitors and Economic Burden in Chinese Population- A Retrospective Analysis Using Claims Database

    May 1, 2018, 00:00

  • Adopting a Pragmatic Methodology to Evaluate Cost-Effectiveness of a Simple Insulin Infusion Device Compared with Multiple Daily Injections in Patients with Type 2 Diabetes on Insulin

    May 1, 2018, 00:00

  • Cost-Effectiveness of Tofacitinib in Patients with Rheumatoid Arthritis in China

    May 1, 2018, 00:00

  • An Investigation of Issues in the Translation and Comprehension of the Concept of Disease Activity in Patient Reported Outcomes (PRO) Measures

    May 1, 2018, 00:00

  • Risk-Stratification Method for Identifying Patients for Care Coordination – Real-World Experience in the Health Plan, Brazil

    May 1, 2018, 00:00

  • Comparing Clotting Factors Benefit-Risk Attributes Across Different Methods of Preference Elicitation In Hemophilia Patients

    May 1, 2018, 00:00

  • Estimating the Global Diagnosed Prevalence of Crohn's Disease 2017-2027

    May 1, 2018, 00:00

  • Estimating the Current Cost of Endoscopic Sinus Surgery in the US – A Claims-Based Approach

    May 1, 2018, 00:00

  • Body Mass Index and Obesity-Related Comorbidities Among Patients Aged65 Years Undergoing Bariatric Surgery- Comparison Between Medicare and Commercially-Insured

    May 1, 2018, 00:00

  • Using Time Trade-Off (TTO) Surveys To Measure Health Utilities Associated with Different Urinary Catheter Innovations

    May 1, 2018, 00:00

  • Model-Based Evaluation of the Efficacy and Safety of Burosumab, A Fully Human Anti-FGF23 Monoclonal Antibody, In Adolescent X-Linked Hypophosphatemia (XLH)

    May 1, 2018, 00:00

  • History of Lipid Lowering Therapy and Cardiovascular Medication Use Among Patients Initiating PCSK9 Inhibitors in the United States

    May 1, 2018, 00:00

  • Health Resource Burden Among Patients with Severe Aplastic Anemia who Have Had Insufficient Response to Immunosuppressive Therapy- A Retrospective Chart Review Study

    May 1, 2018, 00:00

  • The Economic Burden of Overactive Bladder (OAB) in Brazil- A Retrospective Observational Study Using Data from the Sistema Unico De Saude (SUS)

    May 1, 2018, 00:00

  • Do Fathers of a Newborn get Depressed? Paternal Postnatal Depression in Riyadh, Saudi Arabia

    May 1, 2018, 00:00

  • Budget Impact Analysis of a Novel Alternating Pressure Support Surface in the Acute Care Setting

    May 1, 2018, 00:00

  • Association Between Bleeding Events and Non-Drug Direct Costs in Adults with Severe Hemophilia A

    May 1, 2018, 00:00

  • Hospital Lenght of Stay and Costs in Patients with Post Operative Wound Infection- Analysis of US National In-Patient Data for 2015 Using ICD-9 and ICD-10 Diagnoses

    May 1, 2018, 00:00

  • Cost Per Response of Certolizumab Pegol Versus Adalimumab Among Biologic-Naïve Patients With Moderate or Severe Rheumatoid Arthritis from the US Payer Perspective

    May 1, 2018, 00:00

  • Impact of 2017 Policy Changes on China's Pharmaceutical Market

    May 1, 2018, 00:00

  • A Review Of Factors Associated With Access To Care In Breast Cancer Patients

    May 1, 2018, 00:00

  • HIV Treatment Guidelines and Medication Initiation Patterns in Treatment Naïve Adults, 2008-2016

    May 1, 2018, 00:00

  • Predictors of Laparoscopic Hysterectomy for Leiomyoma Surgical Removal in the United States

    May 1, 2018, 00:00

  • Changes in Fda Post-Marketing Commitments to Support The Pregnancy and Lactation Labeling Rule

    May 1, 2018, 00:00

  • Potential Cost-Effectiveness of Neratinib Following Trastuzumab Therapy for Treatment of Early-Stage Her2-Positive Breast Cancer

    May 1, 2018, 00:00

  • Financial Benefit of a New Ultrasonic Energy Device in Open and Laparoscopic Procedures

    May 1, 2018, 00:00

  • Quality Assurance Metrics for Prostate Cancer Treatment Plans in the Private Healthcare Environment

    May 1, 2018, 00:00

  • Healthcare Resource Utilization of Conjunctivitis in the General Population and in Patients with Prior Antibiotic-Resistant Infection- A Retrospective US Claims-Based Analysis

    May 1, 2018, 00:00

  • Comparative Effectiveness of a Bilayered Living Cellular Construct and an Acellular Fetal Bovine Collagen Dressing in the Treatment of Venous Leg Ulcers

    May 1, 2018, 00:00

  • Hepatitis C Patient Characteristics and Overall Charges from an Integrated Health Care Delivery System

    May 1, 2018, 00:00

  • Treatment Patterns PSO

    May 1, 2018, 00:00

  • Patella Fracture- Cost, Complications and Treatments in the Commercially-Insured Population

    May 1, 2018, 00:00

  • Comparison of Healthcare Resource Utilization (HRU) and Costs Related to Pleural Effusion (PE) Between Patients Newly Diagnosed with Chronic Myeloid Leukemia (CML) Treated with Dasatinib or Nilotinib as First-Line Therapy in the United Stat ...

    May 1, 2018, 00:00

  • Male Osteoporosis Highly Underdiagnozed in Bulgaria – A Retrospective Analysis

    May 1, 2018, 00:00

  • Comorbidities, Complications, and Surgical Procedures in Type 2 Diabetes Patients- Retrospective Analysis of Electronic Health Record Data

    May 1, 2018, 00:00

  • Budget Impact Analysis of Cladribine Tablets for Treatment Of Patients with Relapsing-Remitting Multiple Sclerosis In Bulgaria

    May 1, 2018, 00:00

  • Health Utility of Hospitalized Stroke Patients in Vietnam, Comparing Early Stage to Discharge

    May 1, 2018, 00:00

  • Burden of Chronic Hepatitis C (CHC) from the Patient Perspective- A Literature Review and Conceptual Map

    May 1, 2018, 00:00

  • Correlates of Oncology Drug Prices in the U.S

    May 1, 2018, 00:00

  • Impact of Chlorhexidine Bathing on Antimicrobial Utilization in Surgical Intensive Care Unit Patients- A Secondary Analysis of a Single-Center Randomized Controlled Trial

    May 1, 2018, 00:00

  • A Cross Sectional Study of the Factors that Affect Therapy Adherence in Children with Attention Deficit Disorder/ Attention Deficit/Hyperactivity Disorder

    May 1, 2018, 00:00

  • The Association Between Preoperative Hemoglobin Values and Hospitalization Outcomes Following Elective Primary Total Joint Replacement

    May 1, 2018, 00:00

  • A Qualitative Physician Focus Group Study to Determine How Physicians Decide What Second-Line Therapy to Prescribe for Patients with Type 2 Diabetes (T2DM)

    May 1, 2018, 00:00

  • Assessment-Time Bias- Statistical Approaches to Adjusting for Between-Trial Differences in the Schedule of Assessment for Disease Progression In Immuno-Oncology Trials

    May 1, 2018, 00:00

  • Assessing Multi-Criteria Decision Analysis (MCDA) Attribute Weights Using an Interactive Data Capture Tool

    May 1, 2018, 00:00

  • Mission Possible? Demonstrating Robust Cost-Effectiveness without Any Comparative Phase 3 Data

    May 1, 2018, 00:00

  • Off-Label Chemotherapy In Cancer- A Review Of Current Coverage Landscape And Reimbursement Considerations

    May 1, 2018, 00:00

  • Hospitalization Costs for Treatment of Periprosthetic Fractures of the Knee Using Medicare Claims and A Hospital Billing Data in the United States

    May 1, 2018, 00:00

  • Development and Preliminary Assessment of the Environment-Based Quality Of Life (EBQOL) Instrument

    May 1, 2018, 00:00

  • Veno-Occlusive Disease (VOD) Associated with Gemtuzumab Ozogamicin (GO) and Inotuzumab Ozogamicin- Analysis of the FDA Adverse Event Reporting System

    May 1, 2018, 00:00

  • Are all Endoscopic Surgical Staplers the Same? Findings From a Real-World Assessment in Bariatric Procedures

    May 1, 2018, 00:00

  • Cost-Effectiveness of Ibrutinib and Rituximab for the Relapsed or Refractory Chronic Lymphocytic Leukemia in China

    May 1, 2018, 00:00

  • Comparative Effectiveness of Second-Line Anti-Diabetic Agents in Delaying Treatment Intensification

    May 1, 2018, 00:00

  • Cancer Drug Reimbursement Decision-Making in the Republic of Ireland- Can the Process Be Made More Transparent and Systematic?

    May 1, 2018, 00:00

  • The Impact Of Medicare Part D Drug Coverage On Total Prescription Drug Expenditures Among Cancer Patients In 2014

    May 1, 2018, 00:00

  • What Factors May Impact the Likelihood of First Abbreviated New Drug Application (ANDA) Submission for a Reference Product?

    May 1, 2018, 00:00

  • Budget Impact Analysis of Basaglar for the Treatment of Type 1 and Type 2 Diabetes in Patients Eligible for a Long-Acting Insulin Analog

    May 1, 2018, 00:00

  • Geographic Variation in Opioid Related Inpatient Healthcare Utilization in the United States- A Retrospective Study of a Large Health System’s Claims Data

    May 1, 2018, 00:00

  • Cost-Effective Study of Alectinib in Treating Crizotinib-Failed Anaplastic Lymphoma Kinase Positive (ALK+) Non-Small Cell Lung Cancer (NSCLC) Patients in Taiwan

    May 1, 2018, 00:00

  • Indirect Costs of a Relapse in Schizophrenia in Mexico

    May 1, 2018, 00:00

  • Bayesian Network Meta-Analysis of Treatments in Iron Deficiency Anaemia (IDA)

    May 1, 2018, 00:00

  • Comparing the EQ-5D-3L and EQ-5D-5L in a Cohort of Cancer Patients

    May 1, 2018, 00:00

  • Comparative Effectiveness Of Edoxaban And Warfarin In Prevention Of Stroke And Systemic Embolism In Non-Valvular Atrial Fibrillation Using Observational Healthcare Data

    May 1, 2018, 00:00

  • Comparison of Costs Associated with Turp and Prostatic Urethral Lift for Benign Prostatic Hyperplasia

    May 1, 2018, 00:00

  • A Systematic Review of Health Economic Evaluations in Mexico

    May 1, 2018, 00:00

  • Examining Epidemiological Burden of Sepsis in the Chinese Population Using a Focused Literature Review

    May 1, 2018, 00:00

  • Patient Preferences for Health States Following Alternative Management Options for Ductal Carcinoma in Situ

    May 1, 2018, 00:00

  • Adaptive Licensing and Real World Evidence (RWE)

    May 1, 2018, 00:00

  • Health Techonolgy Assessment (HTA) Agencies Consideration of Real World Evidence (RWE)

    May 1, 2018, 00:00

  • An Appraisal of the Quality of Economic Evidence in Cost-Effectiveness and Cost-Utility Studies Identified Via Systematic Review for B-Type Natriuretic Peptide-Guided Therapy in Heart Failure Management Patients

    May 1, 2018, 00:00

  • Return on Investment (ROI) of Value-Based Insurance Design (VBID) Programs for Diabetic Patients

    May 1, 2018, 00:00

  • Comparison of Real-World Costs Between Patients with Rheumatoid Arthritis Treated with Subcutaneously-Administered Biologics Previously Treated with Another Biologic

    May 1, 2018, 00:00

  • Clinical Core Outcomes Sets in Real World Data

    May 1, 2018, 00:00

  • Real-World EQ-5D-5L Utility Values In Patients With Melanoma Derived Using A Digital ‘Bring Your Own Device’ Platform

    May 1, 2018, 00:00

  • A Tale of two DTM Programs- Drug Therapy Management Reduces Acute Hospitalization and Expenditures in Medicaid Beneficiaries in Michigan and Washington DC

    May 1, 2018, 00:00

  • Hepatitis B Virus (HBV) Vaccine in Pregnancy and Impact on Pregnancy Outcome

    May 1, 2018, 00:00

  • Quantitative Assay of Fecal Calprotectin in Children with Cow’s Milk Protein Allergy

    May 1, 2018, 00:00

  • Measuring Treatment Satisfaction with Medication from Patients’ Perspective- Conceptual Models and a Review of Measures

    May 1, 2018, 00:00

  • Estimation of Total Burden of Head And Neck Cancer in Brazil – An Economic and Clinical Approach

    May 1, 2018, 00:00

  • Outpatient Antibiotic Use and Revisits for Children with Acute Respiratory Tract Infections

    May 1, 2018, 00:00

  • Nasal Glucagon Saves Professional Emergency Medical (EM) Costs Versus Intramuscular Glucagon —A Us Based Cost-Offset Model

    May 1, 2018, 00:00

  • Healthcare Costs Associated with Hyperprolactinemia in the United States

    May 1, 2018, 00:00

  • Initiation of Psychotropic Prescriptions without a Psychiatric Diagnosis in US Adults

    May 1, 2018, 00:00

  • One-Year Clinical Outcomes In Patients With Acute Coronary Syndrome In Tianjin, China

    May 1, 2018, 00:00

  • Cost-Effectiveness of Tacrolimus for the Treatment of Moderate-to-Severe Lupus Nephritis

    May 1, 2018, 00:00

  • Coverage and Reviews of Medical Devices, Genomic and Diagnostic Testing by US Health Plans

    May 1, 2018, 00:00

  • Use of Medical Transcription Data for Real World Clinicogenomic Evidence Generation for Mental Health Disorders In US

    May 1, 2018, 00:00

  • Cost-Effectiveness of Crizotinib for Second and Third-Line Treatment of Non-Small Cell Lung Cancer in Ecuador

    May 1, 2018, 00:00

  • Cost-Effectiveness Analysis of Regorafenib for Third-Line Metastatic Colorectal Cancer (MCRC) Compared to Cetuximab Plus Irinotecan in China

    May 1, 2018, 00:00

  • Kidney Function, Polypharmacy, and Potentially Inappropriate Medication Use in a Community-Based Cohort of Older Adults

    May 1, 2018, 00:00

  • A Comparison of the Treatment Recommendations for Neurogenic Bladder in the National Institute for Health and Care Excellence, European association of Urology and International Consultations on Incontinence Guidelines

    May 1, 2018, 00:00

  • Diffusion without Eviden A Study on High-Risk Medical Devices

    May 1, 2018, 00:00

  • Budget Impact Analysis of Implementing 5mm Dual-Ended Safety Pen Needles for Insulin Injections in US Hospitals

    May 1, 2018, 00:00

  • Assessment of Commercial and Market Access Potential and Considerations for an Ultra-Orphan Drug for Renal Disease in EU5

    May 1, 2018, 00:00

  • Malnutrition and Vaccination in Children- Case of Post-Conflict Zone in Colombian Caribean

    May 1, 2018, 00:00

  • Comparison of Video-Assisted Thoracic Surgery Segmentectomy (VATS-S) Versus Video-Assisted Thoracic Surgery Lobectomy (VATS-L) for Stage I Non-Small Cell Lung Cancer (NSCLC-I) in Chinese Patients- A Systemic Review and Meta-Analysis

    May 1, 2018, 00:00

  • A Modified Parametric Approach to Model Long-Term Survival of Potentially Curative Therapies- Implications for the Cost-Effectiveness of Car-T Therapies

    May 1, 2018, 00:00

  • Gastrointestinal Events in Melanoma Patients Treated with Ipilimumab and Nivolumab

    May 1, 2018, 00:00

  • Health Care Costs in Diabetes- The Role of Comorbidity Type

    May 1, 2018, 00:00

  • Association of the Hospital Cost for Copd with GDP Per Capita- Evidence for Brazilian States, 2000-2014

    May 1, 2018, 00:00

  • Missed Opportunities for Influenza and Pneumococcal Vaccinations in the Elderly in the US - A Cross-Sectional Analysis

    May 1, 2018, 00:00

  • Comparison of Buprenorphine and Methadone Based Medication Assisted Treatments (MAT) for Opioid use Disorder (OUD) Among Pregnant Women with Commercial Insurance

    May 1, 2018, 00:00

  • Trends in Hospitalization Lenght of Stay, Seasonality and Costs in Patients with Respiratory Syncytial Virus Infection- Analysis of US National In-Patient Data for 2015 Using ICD-9 and ICD-10 Diagnoses

    May 1, 2018, 00:00

  • United States Valuation of EQ-5D-5L Health States- An Initial Model Using a Standardized Protocol

    May 1, 2018, 00:00

  • Influence Of Critical Disease Insurance (CDI) Policy On Pemetrexed Adherence Among The First-Line Non-Squamous Non-Small Cell Lung Cancer (NSCLC) Patients In Zhejiang Province Of China

    May 1, 2018, 00:00

  • Improving Medication Adherence By Better Targeting Interventions Using Artificial Intelligence - A Randomized Control Study

    May 1, 2018, 00:00

  • Adjuvant Chemotherapy Use For Stage II Colon Cancer In Medicare Population

    May 1, 2018, 00:00

  • Cost-Effectiveness Analysis of Myostrain in Suspected Coronary Artery Disease Patients

    May 1, 2018, 00:00

  • Financial Impact and Experience with General Medical Services Among Cancer Survivors in the United States

    May 1, 2018, 00:00

  • Effects of Galcanezumab on Healthcare Resource Utilization and Acute Medication Use in Patients with Migraine- Results from Two Global Phase 3 Clinical Trials

    May 1, 2018, 00:00

  • Descriptive Results from the Prescription Opioid Misuse and Abuse Questionnaire (POMAQ) Validation Study

    May 1, 2018, 00:00

  • Accessing Newly Implemented Claims Databases In Southeast-Asia- Advancing Health Research

    May 1, 2018, 00:00

  • Cost-Effectiveness Analysis of Daratumumab, Lenalidomide, and Dexamethasone (DRD) and Daratumumab, Bortezomib, And Dexamethasone (DVD) Versus Standard of Care in Relapsed or Refractory Multiple Myeloma (RRMM)

    May 1, 2018, 00:00

  • Cost-Utility Analysis of Initial Treatment with Apremilast Versus Methotrexate in Systemic-Naïve Patients with Plaque Psoriasis

    May 1, 2018, 00:00

  • Patterns of Use of Disease Modifying Treatments Among Patients with Relapsing Remitting Multiple Sclerosis in Europe Between 2012 and 2016

    May 1, 2018, 00:00

  • A Wrinkle In Time- When Survival Estimates Change Over The Observation Period

    May 1, 2018, 00:00

  • Cost Treatment Comparison of Abiraterone Acetate Plus Prednisone in the Pre-Chemotherapy Setting Followed by Enzalutamide in the Post-Chemotherapy Setting Versus the Opposite Treatment Sequence in Metastatic Castration-Resistant Prostate Ca ...

    May 1, 2018, 00:00

  • Quantifying the Monitoring Burden of Multiple Sclerosis (MS) Treatment in the United Kingdom (UK)- Feasibility Phase for an Observational Time and Motion (TM) Study

    May 1, 2018, 00:00

  • Cost-Minimization Analysis of Adding a New Single Inhaler Triple Therapy (SITT) for the Treatment of Patients with Chronic Obstructive Pulmonary Disease (Copd) in the UK

    May 1, 2018, 00:00

  • Improving the Quality and Efficiency of Care Delivery Through In-Depth Understanding of the China Healthcare Digital Landscape

    May 1, 2018, 00:00

  • Challenges in Valuing Temporary Health States for Economic Evaluation- A Review of Empirical Applications of the Chained Time Trade-Off Method

    May 1, 2018, 00:00

  • 12-Month Healthcare Utilization In Medicare Fee-For-Service Patients With Clinically Significant Mitral Regurgitation

    May 1, 2018, 00:00

  • The Effect of Generic Price Competition on Retail and Wholesale Margins on the Hungarian Statin Market

    May 1, 2018, 00:00

  • Prior Perceptions and Subsequent Decisional Conflict Regarding HIV Cure Trial Participation in Bangkok, Thailand

    May 1, 2018, 00:00

  • Pharmacoeconomics in Nepal- Need For A Paradigm Shift

    May 1, 2018, 00:00

  • Economic Evaluation of the Confirmatory Antibody Assay Against HIV-1 and HIV-2 (Geenius™ HIV 1/2 Supplemental Assay) as Confirmatory and Differentiation HIV Test

    May 1, 2018, 00:00

  • Estimated Number of Deaths Due to Pneumonia in High Risk Patients According to Nip- A Retrospective Study in Brazilian Public Health

    May 1, 2018, 00:00

  • Are mother’s Behavior, Health Status, and Birth Experience Associated with Low Birth Weight in South Carolina? Evidence from Prams, 2004-2013

    May 1, 2018, 00:00

  • The Impact of Patient-Centered Medical Home on Hypertension-Associated Health Care Utilization and Cost

    May 1, 2018, 00:00

  • Nice-ly Paving the Way? Dynamic Pricing- The Future of Pricing and Reimbursement?

    May 1, 2018, 00:00

  • Prevalence and Duration of Skeletal Muscle Relaxant Treatment Among Commercially Insured Adults in the United States from 2005 to 2015

    May 1, 2018, 00:00

  • Projected Savings in Direct and Indirect Costs Due to Reduced Diabetes Prevalence with Vegetarian Diets

    May 1, 2018, 00:00

  • Factors Predicting Restrictions on US Commercial Payer Coverage of Specialty Drugs

    May 1, 2018, 00:00

  • Anti-PD1 Drugs- Are The Reimbursed Indications Of The Marketing Authorization Respected?

    May 1, 2018, 00:00

  • Relative Risk and Crude Mortality Among Cohorts of US Medicare Beneficiaries with Autosomal Dominant Polycystic Kidney Disease

    May 1, 2018, 00:00

  • Concepts and Instruments for Patient-Reported (PRO) Assessment in Celiac Disease- Literature Review and Stakeholder Perspectives

    May 1, 2018, 00:00

  • Trends in Hospitalization Lenght of Stay and Costs in Patients with Peripheral T-Cell Lymphoma (PTCL)- Analysis of US National In-Patient Data for 2015

    May 1, 2018, 00:00

  • Lack of Association Between Beta Blocker Use and Reduction in Joint Pain and Analgesic Use Among Participants with Symptomatic Radiographic Knee Osteoarthritis

    May 1, 2018, 00:00

  • Outcomes Among Patients Prescribed Atypical Long-Acting Injectables Vs Oral Antipsychotic Therapy Following an Acute Event for Schizophrenia

    May 1, 2018, 00:00

  • The Relationship Between Compliance and Blindness Prevention in Economic Models for Diabetic Retinopathy Screening

    May 1, 2018, 00:00

  • Health Technology and Regulatory Assessment of Adherence and Improved Outcomes for Second Generation Antipsychotics in Schizophrenia

    May 1, 2018, 00:00

  • Impact of Elagolix on Health-Related Quality of Life Among Patients with Moderate to Severe Endometriosis-Associated Pain- Analysis of EQ-5D-5L Data from a Phase III Randomized Controlled Trial

    May 1, 2018, 00:00

  • Patterns Of Use And Quality Of Life (QOL) Associated With The Utilization Of Antidepressants Amongst Cancer Patients With Depression

    May 1, 2018, 00:00

  • Multi-Level Predictors of Discharges Against Medical Advi Decomposing Variation Using an All-Payer Database

    May 1, 2018, 00:00

  • Budget Impact Analysis (BIA) of Point-of-Care of HBA1C Monitoring in Belgian, German and Swiss Patients with Diabetes Mellitus Type II

    May 1, 2018, 00:00

  • Assessing the Benefits of Co-Pay Card Usage Among Diabetic Patients in Canada

    May 1, 2018, 00:00

  • The Use of Real World Data to Define The Prevalence, Severity, and Etiology of Mitral Valve Regurgitation

    May 1, 2018, 00:00

  • Clinical Utility of Promis Domain Scales- Thresholds for Determining Responsiveness Following Stroke

    May 1, 2018, 00:00

  • An Open-Source Toolkit for Developing Flexible Evidence-Based Decision and Simulation Models for Value Assessment in Oncology with R

    May 1, 2018, 00:00

  • Healthcare Resource Utilisation and Costs of Agitation in People with Demetia Living in Care Homes - The Managing Agitation and Raising Quality of Life in Dementia (MARQUE) Study

    May 1, 2018, 00:00

  • Employer-Perspective Cost Comparison of Surgical Treatments for Abnormal Uterine Bleeding

    May 1, 2018, 00:00

  • Handling Data Quality Issues to Estimate the Spanish EQ-5D-5L Value Set Using a Hybrid Interval Regression Approach

    May 1, 2018, 00:00

  • A Systematic Review of Population-Based Studies on Pain Self-Management Strategies and Outcomes

    May 1, 2018, 00:00

  • Budget Impact of Etanercept Versus Adalimumab for Treatment of Rheumatoid Arthritis In Biologic-Naïve Patients in the United Kingdom

    May 1, 2018, 00:00

  • Identification of Potentially Inappropriate Cardiovascular Prescriptions in the Elderly Using Beers Criteria in Colombia

    May 1, 2018, 00:00

  • Real-World, Non-Interventional, Observational, Patient Reported Outcome Study for Evaluating Effectiveness of Intensive Moisturizing Cream with Plant Based Butters (Venusia Max) in Management of Indian Patients with Psoriasis

    May 1, 2018, 00:00

  • Examining Job Satisfaction, Stress, Flexibility, And Career Success Factors in the Health Economics, Outcomes Research, And Market Access (HEORMA) Profession Based on a Global Cross-Sectional Study

    May 1, 2018, 00:00

  • Patterns Of Health Service Utilization Among Patients Undergoing Hematopoietic Cell Transplantation — A Person-Centered Approach

    May 1, 2018, 00:00

  • Patient Satisfaction, Adherence , Compliance , Persistence in Healthcare . Preliminary Real-World Evidence (RWE) in a Private Health Insurance in Latin America Country

    May 1, 2018, 00:00

  • Cancer-Associated Venous Thromboembolism (VTE) Prophylaxis- A Comparative Effectiveness Research

    May 1, 2018, 00:00

  • Cost-Minimization Analysis of Biological Drugs in the Treatment of Ankylosing Spondylitis from a Brazilian Perspective

    May 1, 2018, 00:00

  • The Economic Burden of Erectile Dysfunction and Related Comorbidities- A Medicare Perspective

    May 1, 2018, 00:00

  • Practical Implications of Flexible Work Arrangements – A Survey of Selected Pharmaceutical/Healthcare Organizations

    May 1, 2018, 00:00

  • A Time-Motion Observational Study of Clinic Staff- Administration of Pegfilgrastim Primary Prophylaxis Via Next-Day Manual Injection and On-Body Injector (OBI)

    May 1, 2018, 00:00

  • Effect of Vitamin D Supplementation on HIV Outcomes- A Systematic Review and Meta-Analysis of Randomized Controlled Trials

    May 1, 2018, 00:00

  • Estimating the Cost and Cost-Effectiveness for Obstetric Fistula Repair in Low-Income Countries

    May 1, 2018, 00:00

  • Application of Generalized Structural Equation Model in a 41-Year Cohort Study of Incident and Survival Outcomes of Rheumatoid Arthritis (RA) Cases and Matched Non-Ra Controls

    May 1, 2018, 00:00

  • Cost-Effectiveness of Three Different Strategies for the Treatment of First Recurrent Clostridium Difficile Infection Diagnosed in a Community Setting

    May 1, 2018, 00:00

  • FLT3 Mutated and Wildtype Acute Myeloid Leukemia Treatment Patterns and Outcomes at a Comprehensive Cancer Center

    May 1, 2018, 00:00

  • Health Technology Assessment of Gene Therapies for Inherited Genetic Disorders in the US and Europe

    May 1, 2018, 00:00

  • Efficacy and Safety of Everolimus in the Treatment of Metastatic Breast Cancer- A Systematic Review and Meta-Analysis

    May 1, 2018, 00:00

  • Clinical Characteristics, Rescue Treatments, Health Resources Utilization, and Medical Costs Associated with Chinese Chronic Hepatitis B Patients with Drug Resistance to Neucleot(S)IDE Analogues- A Retrospective Cohort Study

    May 1, 2018, 00:00

  • Diabetes Mellitus and Suicide Risk in Males and Females- A Literature Review

    May 1, 2018, 00:00

  • The Association Between Airflow Limitation and Early Retirement Using the Health Retirement Survey Data

    May 1, 2018, 00:00

  • The Impact of Judicialization of Eculizumab on the Budget of Brazilian Health System

    May 1, 2018, 00:00

  • Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer- Real-World Clinical Characteristics, Treatment Patterns, And Health Care Resource Utilization In Europe

    May 1, 2018, 00:00

  • EQ-5D-3L Decrements By Diabetes Complications and Comorbidities in China

    May 1, 2018, 00:00

  • 1. Indirect Treatment Comparison of Pembrolizumab Versus Standard-of-Care for Relapsed and Refractory Classical Hodgkin’s Lymphoma Using Time-Varying Hazard Ratios

    May 1, 2018, 00:00

  • A Comparison of T2DM Patient Characteristics in 2009-2012 Vs. 2013-2016 Using Data from the Malaysian National Diabetes Registry

    May 1, 2018, 00:00

  • The Hospital Burden Of Amputation In Patients With Peripheral Artery Disease

    May 1, 2018, 00:00

  • Clinical Outcome Assessments- Use of Normative Data in a Pediatric Rare Disease

    May 1, 2018, 00:00

  • Effect of Painful Lumbosacral Radiculopathy on Employment and Quality of Life Among Patients in Europe

    May 1, 2018, 00:00

  • Comparison of All-Cause Mortality and All-Cause Hospitalization Risk for Medications to Treat Alzheimer’s Disease

    May 1, 2018, 00:00

  • A Discrete Event Simulation Model For A Pharmacogenomics Test For Statin-Induced Myopathy In Patients Initiating A Statin In Secondary Cardiovascular Prevention

    May 1, 2018, 00:00

  • Cervical Cancer Screening Decision Model

    May 1, 2018, 00:00

  • “It’s Tough to Make Predictions, Especially About the Future”- Comparing Life Expectancy Predictions Based on Period Versus Cohort Life Tables

    May 1, 2018, 00:00

  • Social and Economic Impact of Patients with Metastatic Breast Cancer in Brazil

    May 1, 2018, 00:00

  • Baseline Knowledge About Vaccines and Vaccine-Preventable Diseases Among Older Adults- Preliminary Baseline Analysis of the Vaccine Education Through Pharmacists and Senior Centers (VEPSC) Study

    May 1, 2018, 00:00

  • Systematic Review of Patient Perspectives and Quality of Life Outcomes Associated with Use of Topical Interventions for Treatment of Chronic Wounds

    May 1, 2018, 00:00

  • Cost-Effectiveness of Staged Direct-Acting Antiviral Treatment Policies in an Integrated Healthcare System

    May 1, 2018, 00:00

  • Leveraging Social Media to Explore Patient Experiences in Neovascular Age-Related Macular Degeneration

    May 1, 2018, 00:00

  • The Economic Burden Among Patients with Treatment Resistant Depression in US Claims Data

    May 1, 2018, 00:00

  • Evaluation of the Cost Per Patient Achieving Composite and Single Treatment Targets with Once-Weekly Semaglutide and Exenatide ER in the United States

    May 1, 2018, 00:00

  • Costs Associated with Follicular Lymphoma Among Medicare Beneficiaries- An Incremental Cost Analysis

    May 1, 2018, 00:00

  • Experiences of Health and Social Inequalities in African Asylum Seekers and Refugees In Manchester, UK- A Thematic Analysis

    May 1, 2018, 00:00

  • Cost Effectiveness Analysis Of Evolocumab, A PCSK9 Inhibitor, From The US Societal Perspective

    May 1, 2018, 00:00

  • Ultrasound- A Fast Low-Cost Tool for the Diagnosis of Rheumatoid Arthritis in a Specialized Center

    May 1, 2018, 00:00

  • Use And Expense Of Antihypertensive Medicines In U.S. Hypertensive Adults

    May 1, 2018, 00:00

  • Quality of Life in Patients with Osteoporosis- A Us Cross-Sectional Survey

    May 1, 2018, 00:00

  • Projecting Overall Survival (OS) With Immuno-Oncology (IO) Treatments- Application of Alternative Approaches in Metastatic Merkel Cell Carcinoma (MMCC)

    May 1, 2018, 00:00

  • Assessing Symptom Change at the Individual Level Using Item Response Theory Versus Sum Scoring- Implications for Depression Treatment

    May 1, 2018, 00:00

  • Systematic Review and Decision Analysis for Current and Experimental Therapies for Wiskott-Aldrich Syndrome

    May 1, 2018, 00:00

  • The Effect of Physical Activity During Pregnancy on Quality of Life

    May 1, 2018, 00:00

  • Economic Guidance Panel Changes to Minimize Post-Progression Treatment Effects by the Pan-Canadian Oncology Drug Review in Economic Evaluations Assessing Cancer Drugs

    May 1, 2018, 00:00

  • Predictors of Annual Salary for Health Economics, Outcomes Research, and Market Access Professionals

    May 1, 2018, 00:00

  • Impact of Elagolix on Quality of Life Measured By SF-12 in Women with Heavy Menstrual Bleeding Associated with Uterine Fibroids- Evidence from A Phase 2B Randomized Trial

    May 1, 2018, 00:00

  • First Steps in Choosing Appropriate Instruments/Measurements for a Core Outcome Set- An Example from Corehem

    May 1, 2018, 00:00

  • Outcomes Related to Opioid Prescribing after Academic Detailing- A Review of Literature

    May 1, 2018, 00:00

  • Budget Impact of a Fixed-Dose Combination Therapy of Lesinurad and Allopurinol for Second-Line Gout Therapy- A US Commercial Health Plan Perspective

    May 1, 2018, 00:00

  • Can We Make Better Decisions If We Remove Quality of Life from the Value Equation?

    May 1, 2018, 00:00

  • A Cost-Utility Analysis of Atovaquone-Proguanil vs. Artemether-Lumefantrine for the Treatment of Uncomplicated Malaria in the United States

    May 1, 2018, 00:00

  • Is Facebook Addiction Leading Adolescents to Depression? Evidence from Dhaka City, Bangladesh

    May 1, 2018, 00:00

  • Characterizing Patients Treated With Macitentan For Pulmonary Arterial Hypertension (PAH) In The U.S. Opsumit Users Registry (OPUS)

    May 1, 2018, 00:00

  • Cost-Effectiveness Analysis of Sofosbuvir/Velpatasvir in Genotype 1 Hepatitis C Infected Patients in Mexico

    May 1, 2018, 00:00

  • Association of Appropriate Pharmacotherapy Management of Copd Exacerbation and Risk of Subsequent Readmission

    May 1, 2018, 00:00

  • Cost-Utility Analysis of Trabecular Micro-Bypass Stents Versus Laser Trabeculoplasty for Patients with Open-Angle Glaucoma in Colombia

    May 1, 2018, 00:00

  • The Cost-Effectiveness Analysis of Rhtpo Versus Il-11 on The Treatment of Chemotherapy-Induced Thrombocytopenia Patients in China

    May 1, 2018, 00:00

  • Rehospitalization in Patients with Chronic Obstructive Pulmonary Disease- Important Risk Factors and Risk Prediction Model Using Clarification Random Forest

    May 1, 2018, 00:00

  • Patient and Clinician Satisfaction with Pharmacological Stress Agents (PSAS) Used in Single Photon Emission Computerized Tomography Myocardial Perfusion Imaging (SPECT-MPI)

    May 1, 2018, 00:00

  • The Long-Term Social Value Of Better Targeting G-Csf Therapy To Cancer Patients At Risk Of Febrile Neutropenia

    May 1, 2018, 00:00

  • Price Analysis of Immunosuppressants Which are Approved By FDA as Anti-Rejection Therapy for Kidney Transplantation in the United States

    May 1, 2018, 00:00

  • The Impact of the Centers for Medicare and Medicaid Services (CMS) 2016 Update to the Two-Midnight Rule On Inpatient/Outpatient Status and Length of Stay for Cardiac Ablation Procedures

    May 1, 2018, 00:00

  • Cost-Effectiveness of Treating Overactive Bladder With Mirabegron Versus Antimuscarinics in Mexico

    May 1, 2018, 00:00

  • Abuse-Deterrent Formulations of Opioids- Effectiveness and Economic Impact

    May 1, 2018, 00:00

  • Commercialising Regenerative Medicines in the US – What Lessons can We Learn from Europe?

    May 1, 2018, 00:00

  • Economic Evaluation of the Advance Lubricath® Foley Catheter Tray® for Urinary Catheterization of Long Duration

    May 1, 2018, 00:00

  • ICERS are Not All the Same. How Cost-Effectiveness Estimates Differ Between the UK and US

    May 1, 2018, 00:00

  • The Impact Of Cluster Selection Methods In Two-Stage Bootstrapping To Assess Uncertainty In Health Economic Outcomes In Cluster Randomized Controlled Trials

    May 1, 2018, 00:00

  • The Total Direct Healthcare Expenditures of Diagnosed Drug Dependen Evidence from United States National Survey Data

    May 1, 2018, 00:00

  • The Development of the Guide to Economic Analysis and Research (GEAR) Online Resource for Low- and Middle-Income Countries’ Health Economics Practitioners- A Commentary

    May 1, 2018, 00:00

  • Clinical and Economic Impact of Switching from Negative- or Neutral Displacement Needleless Connectors to Positive Displacement Needleless Connectors in Central Vascular Access Settings

    May 1, 2018, 00:00

  • Incremental Healthcare Resource use and Costs Associated with Skeletal-Related Events in Patients with Bone Metastases from Solid Tumors

    May 1, 2018, 00:00

  • An Exact Method For Estimating Standard Errors From Zero-Inflated Gamma Distributions For Healthcare Cost Data

    May 1, 2018, 00:00

  • Consistency of Drug Labels for Therapeutically Equivalent Medications

    May 1, 2018, 00:00

  • The Influence on Coping Style in Patients with Schizophrenia By Naikan Therapy

    May 1, 2018, 00:00

  • Towards IRP Common Ground- To What Extent are European Countries Aligned in How they use International Reference Pricing?

    May 1, 2018, 00:00

  • Cost-Effectiveness of Empagliflozin in Chinese Patients with Type 2 Diabetes and Established Cardiovascular Disease- A Discrete Event Simulation Economic Modelling Study

    May 1, 2018, 00:00

  • Extent and Predictors of Potentially Inappropriate Antidepressant Use Among Older Adults with Dementia and Major Depressive Disorder

    May 1, 2018, 00:00

  • The Impact Of Regulatory Accelerated Approval Schemes And Htas On Access To New Oncology Medicines- Evidence From 11 Countries

    May 1, 2018, 00:00

  • Cost-Effectiveness and Budget Impact of Introducing Long Acting Atypical Antipsychotics in the United States Healthcare System

    May 1, 2018, 00:00

  • Estimated Budget Impact Of Cholesterol Decreasing In The Russian Population

    May 1, 2018, 00:00

  • Length of Stay, Hospitlization Cost, and In-Hospital Mortality Associated with Tumor Lysis Syndrome Among Patients with Chronic Lymphocytic Leukemia

    May 1, 2018, 00:00

  • Treatment Utilization Patterns Among Elderly Patients Diagnosed With Follicular Lymphoma In The United States Between 2000 And 2013

    May 1, 2018, 00:00

  • Emphasizing Quality of Life in Treatment Recommendations for Node-Positive Stage III Non-Small Cell Lung Cancer

    May 1, 2018, 00:00

  • The Prevalence and Treatment Patterns of Women of Child Bearing Age (WOCBA) with Psoriasis (PSO)

    May 1, 2018, 00:00

  • Annual Direct Medical Cost of Pediatric Pulmonary Hypertension Health Care in Centro Medico Nacional 20 De Noviembre (Nmcissste, Mexico)

    May 1, 2018, 00:00

  • Uptake of all-oral Direct Acting Antivirals in Hepatitis C Virus-Infected Patients with Substance use Disorder

    May 1, 2018, 00:00

  • Healthcare Resource Use (HRU) Associated with Severe Adverse Events (AES) Of Interest in Adults With Relapsed or Refractory (R/R) B-Precursor Acute Lymphoblastic Leukemia (All) In Eu-4 Countries

    May 1, 2018, 00:00

  • A Review of Health Technology Assessments (HTA) of PCSK9 Inhibitors (PSCK9I)

    May 1, 2018, 00:00

  • Identifying Caregiver Priorities for Treatment Endpoints for Prader-Willi Syndrome with Best-Worst Scaling

    May 1, 2018, 00:00

  • Low-Density Lipoprotein Cholesterolgoal Attainment Based on 2015 Korean Dyslipidemia Guidelines

    May 1, 2018, 00:00

  • The Comparative Efficacy, Safety, And Reactogenicity, of Herpes Zoster Vaccines- A Network Meta-Analysis

    May 1, 2018, 00:00

  • Health Care Utilization and Economic Burden of Patients With Inflammatory Bowel Disease in the US Department of Defense Population

    May 1, 2018, 00:00

  • Patient Characteristics and Treatment Patterns in Cancer Patients with Venous Thromboembolism in Korea

    May 1, 2018, 00:00

  • Table of Contents

    May 1, 2018, 00:00

  • Health Insurance Cost Related to the Additional Treatment and Complications of Patients Involved into Clinical Trials

    May 1, 2018, 00:00

  • The Association Between Adherence with Statin Therapy and Risk of Dementia Among Diabetic Patients with Comorbid Hyperlipidemia

    May 1, 2018, 00:00

  • Claims-Based Data Sources Likely Underestimate Use of Human Insulin

    May 1, 2018, 00:00

  • Survival of Patients with Diabetes Mellitus By Residential Area in Colombia, 2008-2017

    May 1, 2018, 00:00

  • Impact of European Medicines Agency (EMA) Clinical Trial Transparency Policies on Health Technology Assessment (HTA) Decisions In the UK

    May 1, 2018, 00:00

  • Hospitalization Outcomes For Adults In The United States With Atrial Septal Defect- Analysis Of A Multicenter Database

    May 1, 2018, 00:00

  • Total Healthcare Expenditures Associated with Biological Anti-Rheumatic Drugs Use Among Medicare Beneficiaries with Rheumatoid Arthritis

    May 1, 2018, 00:00

  • Cost-Effectiveness Analysis of Transcatheter Aortic Valve Replacement in Inoperable Patients with Severe Aortic Stenosis in Mexico

    May 1, 2018, 00:00

  • Healthcare Cost Associated with Cardiac Implantable Electronic Device Infections- Using a National Health Insurance Claims Database

    May 1, 2018, 00:00

  • An Evaluation of the Cost-Effectiveness of Reslizumab in Poorly Controlled Eosinophilic Asthma

    May 1, 2018, 00:00

  • What Is The Future Of Using Outcomes-Based Contracts Between Payers And Pharmaceutical Manufacturers To Gain Market Access For Advanced Oncologic And Biologic Agents?

    May 1, 2018, 00:00

  • The Budget Impact of Brodalumab for the Treatment of Moderate-to-Severe Plaque Psoriasis on U.S. Commercial Health Plans

    May 1, 2018, 00:00

  • Examining the Target Population of Orphan Drugs- Are Drugs Exceeding the Intended Purposes of The Orphan Drug Act?

    May 1, 2018, 00:00

  • The Costs of Intensifying Type 2 Diabetes Patients Treated with Basal Insulin to Basal in Combination with GLP-1- A Physician Survey

    May 1, 2018, 00:00

  • Investigating Adherence in Adults with Type 2 Diabetes (T2DM) Prescribed Antiplatelet Medications for Secondary Prevention Following Acute Coronary Syndrome (ACS) Using Large UK Healthcare Databases

    May 1, 2018, 00:00

  • Rapid Estimation of Smoking-Attributable Mortality and Economic Costs

    May 1, 2018, 00:00

  • Economic Burden of Advanced Cervical Cancer- A Systematic Literature Review

    May 1, 2018, 00:00

  • Quality of Life of Adults with a History of Juvenile Idiopathic Arthritis- A Systematic Review

    May 1, 2018, 00:00

  • Insulin Delivery Systems for Type 1 Diabetes Mellitus - A Comparison Using a Decision Analysis Modeling Approach

    May 1, 2018, 00:00

  • Income/Assets and Race/Ethnicity Effects on Drug Adherence Within the Medicare Part D Low Income Subsidy Population

    May 1, 2018, 00:00

  • Developing an Algorithm to Identify Patients with Acute Intermittent Porphyria in an Administrative Claims Database

    May 1, 2018, 00:00

  • The Direct Cost Burden of Tuberous Sclerosis Complex Among Insured Patients in the US

    May 1, 2018, 00:00

  • Clozapine and Agranulocytosis- Impact of the Risk Evaluation and Mitigation Strategy Program

    May 1, 2018, 00:00

  • Are whole Exome and whole Genome Sequencing Approaches Cost-Effective? A Systematic Review of the Literature

    May 1, 2018, 00:00

  • Trends in Hospitalization Lenght of Stay And Costs in Patients with Chronic Lymphoid Leukemia- Analysis of US National In-Patient Data for 2015

    May 1, 2018, 00:00

  • Analyzing Prescription Data to Target Hard-To-Identify Patient Populations for Clinical Trials- A Case Study in Narcolepsy

    May 1, 2018, 00:00

  • Use of Antibiotics for Children with Acute Respiratory Tract Infections and Its Effects on Outpatient Revisits

    May 1, 2018, 00:00

  • Economic Evaluation of the Use of Linear Accelerator of Electrons for Intraoperative Radiotherapy in the Treatment of Rectal Cancer in Mexico

    May 1, 2018, 00:00

  • Cost-Effectiveness Analysis of Absorbable Adhesion Barrier in Preventing Adhesion Formation after Open Gynecologic Surgeries in China

    May 1, 2018, 00:00

  • Payer Perspectives on Gene Therapy Reimbursement in the United States

    May 1, 2018, 00:00

  • Patient-Reported Outcome Measures in the FDA Pilot Compendium- Meeting Today’s Standards for Patient Engagement in Development?

    May 1, 2018, 00:00

  • The Cost-Effectiveness Analysis Of Shenfu Injection Combined With Conventional Therapy For Heart Failure Patients In China

    May 1, 2018, 00:00

  • Health Care Costs And Resource Utilization Prior To Initiation Of A Prostacyclin Receptor Agonist For Pulmonary Arterial Hypertension In A Real-World Database Representing A Large US Health Plan

    May 1, 2018, 00:00

  • Cost-Effectiveness of Abaloparatide for the Treatment of Postmenopausal Women with Osteoporosis

    May 1, 2018, 00:00

  • Are Single-Patient use Electrocardiograph Cable and Lead Systems During Coronary Artery Bypass Graft Monitoring a Benefit to Healthcare Payers- A Budget Impact Analysis

    May 1, 2018, 00:00

  • Why Most Budget Impact Analyses of Medicines are not Accurate? Quality of Budget Impact Analysis Needs to be Improved

    May 1, 2018, 00:00

  • The Next Level in the Game of Playing for Formulary Preference

    May 1, 2018, 00:00

  • Adherence and Persistence in Medication Assisted Treatment Among Pregnant Women with Opioid use Disorder

    May 1, 2018, 00:00

  • Trends in Type 2 Diabetes Inpatient and Emergency Department Visits and Outcomes Using Electronic Health Record Data

    May 1, 2018, 00:00

  • Association Rule Mining to Identify Frequent Concomitant Use of Prescribed Medications in the Population

    May 1, 2018, 00:00

  • Longitudinal Data from Activity Trackers Show that Those with Greater Inconsistency in Activity Levels are More Likely to Develop More Severe Depression

    May 1, 2018, 00:00

  • Persistence and Adherence at 12 Months with Subcutaneously Administered Biologics Among Biologic-Naive and -Experienced Patients With Psoriatic Arthritis- Analyses From A Us Claims Database

    May 1, 2018, 00:00

  • Prevalence and Factors Associated with Hospital Admission Among US Adults- Nhanes 2005-2014

    May 1, 2018, 00:00

  • Treatment with Prostacyclins Delays and Reduces Hospital Readmissions Among Pah Patients

    May 1, 2018, 00:00

  • Are FDA Accelerated Approvals Unconditional Approvals?

    May 1, 2018, 00:00

  • Incremental Burden of Diabetes Complications on Quality of Life and Healthcare Expenditures in the United States

    May 1, 2018, 00:00

  • Cost Effective Only At A Zero Pri A Real-Time Scenario In Untreated Braf V600 Mutated Metastatic Melanoma?

    May 1, 2018, 00:00

  • Hepatocellular Carcinoma In The Brazilian Public Health System- A Burden Of Illness Model

    May 1, 2018, 00:00

  • A Comparison of Long-Term Patient Outcomes after Heart Valve Replacement with Biological or Mechanical Valves in Medicare Beneficiaries

    May 1, 2018, 00:00

  • Healthcare Resource Utilization Among Patients with Angelman Syndrome Stratified By Age

    May 1, 2018, 00:00

  • Acute Infection Following Transfusion Among Inpatient Elderly in the U.S., as Recorded by Large Administrative Databases During 2012-2017

    May 1, 2018, 00:00

  • Effect of Patient Involvement and Message Format on Perceived Susceptibility and Severity to Breast Cancer

    May 1, 2018, 00:00

  • Risk Based Characterization Applied to a Voluntary Insurer in Colombia

    May 1, 2018, 00:00

  • Cost-Effectiveness Evaluation of Enzalutamide and Abiraterone for the Treatment of Metastatic Castration-Resistant Prostate Cancer Patients Progressing after Docetaxel in the Mexican Public Healthcare System

    May 1, 2018, 00:00

  • Trastuzumab Uptake In HER2-Positive Breast Cancer Patients- A Systematic Review And Meta-Analysis Of Observational Studies

    May 1, 2018, 00:00

  • Real Life Use of Dressings in the Treatment of Leg Ulcers and Diabetic Foot Ulcers

    May 1, 2018, 00:00

  • Atypical Antipsychotic Use Among Long-Term Care Residents with Parkinson's Disease and Comorbid Depression

    May 1, 2018, 00:00

  • The Burden of Sickle Cell Disease

    May 1, 2018, 00:00

  • Variation in Physician’s Recommendation of Blood Pressure Self-Monitoring in the United States- Results from Nhanes 2009 – 2014

    May 1, 2018, 00:00

  • Geographic Variation in Opioid Related Outpatient Healthcare Utilization in the United States- A Retrospective Study of a Large Health System’s Claims Data

    May 1, 2018, 00:00

  • A Review of Nice Technology Appraisals in Oncology Using Single Arm Trials (SAT) Evidence

    May 1, 2018, 00:00

  • The Burden of Hypoglycemia in Patients With Insulin-Treated Diabetes Mellitus in China- Analysis of Medical Record Data

    May 1, 2018, 00:00

  • The Reporting Quality of Pharmacoeconomic Studies Before and After Publication of the Cheers Checklist

    May 1, 2018, 00:00

  • Cost-Utility Analysis Of Valsartan Versus Valsartan Plus Hydrochlorothiazide In Patients With Hypertension In The US

    May 1, 2018, 00:00

  • Potential Impact of Changes to Basket of Comparator Countries from PMPRB7 to Pmprb12 has on Canadian Product List Prices

    May 1, 2018, 00:00

  • Examination of Osteoporosis and Subsequent Fracture Risk

    May 1, 2018, 00:00

  • Age and Racial Disparities in Human Pappilomavirus (HPV) Vaccination Series Completion in Mississippi Medicaid

    May 1, 2018, 00:00

  • Patient Preferences for Social Incentives for Medication Adheren A Discrete Choice Experiment

    May 1, 2018, 00:00

  • Psychometric Evaluation of Questionnaires Assessing Injection Regimen Burden in Growth Hormone Deficient (GHD) Adults and Children Treated with Growth Hormone

    May 1, 2018, 00:00

  • Health Care Cost in the Last Year of Life In People with a Private Health Policy from Colombia

    May 1, 2018, 00:00

  • A Foot In The Door Or One Foot In The Grave? The Role Of Real World Evidence In Cancer Drugs Fund Re-Appraisals

    May 1, 2018, 00:00

  • Disease Burden Among Patients with Multiple Sclerosis Not Receiving Disease Modifying Treatments in Europe and the United States

    May 1, 2018, 00:00

  • Hospital Budget Impact Analysis For Giapreza In The Treatment Of Severe Distributive Shock In The Intensive Care Unit

    May 1, 2018, 00:00

  • Cost of Laparoscopic Fundoplication for Gastroesophageal Reflux Disease (GERD) in the US Adult Population

    May 1, 2018, 00:00

  • Cost-Effectiveness of Niraparib and Olaparib as Maintenance Therapy for Patients with Platinum Sensitive Recurrent Ovarian Cancer

    May 1, 2018, 00:00

  • Adherence or Persisten Is that the Question?

    May 1, 2018, 00:00

  • Examinations Of Attitudes Of Romany Minority Women Towards Cervical Cancer Screening

    May 1, 2018, 00:00

  • Trends in Hospitalization Charges for Patients Diagnosed with Elixhauser Comorbidites as a Function of Body Mass Index

    May 1, 2018, 00:00

  • Cost of Care for Patients with Metastatic Castration-Resistant Prostate Cancer in US Commercially Insured and Medicare Supplement Plans

    May 1, 2018, 00:00

  • Designing Evidence Generation Plans for Digital Health Technologies to Gain Reimbursement Coverage in the us

    May 1, 2018, 00:00

  • The Study of the Present Situation and Problems Related to the Drug Safety Monitoring Acted by Pharmacists of Hospitals Under the New Medical Reform in China—Based on the Result of in-Depth Interview

    May 1, 2018, 00:00

  • Defining and Estimating the Cure Fraction Bias in Survival Modelling of Novel Immuno-Oncology Therapy Agents in Small-Cell Lung Cancer

    May 1, 2018, 00:00

  • Overall Treatment Satisfaction with Schizophrenia Therapies- Analysis from Patient, Physician and Caregiver Perspectives

    May 1, 2018, 00:00

  • Biosimilars- The Challenge to Overcome Financial Incentives in a US Payer Market

    May 1, 2018, 00:00

  • Thai Adults’ Preferences and Willingness-To-Pay for Colorectal Cancer Screening- A Discrete Choice Experiment

    May 1, 2018, 00:00

  • Budget Impact Analysis of Biologic Dmards in Colombia

    May 1, 2018, 00:00

  • Effect of a Provider-Focused Asthma Care Quality Improvement Program on Patient-Level Asthma-Related Health Care Costs

    May 1, 2018, 00:00

  • ICD-Coded Information on Sites of Metastasis in Oncology Real-World Data is Specific but Not Sensitive

    May 1, 2018, 00:00

  • Systematic Literature Review of Treatments for Patients with Untreated Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

    May 1, 2018, 00:00

  • Economic Analysis of D-Dimer Test used for the Diagnosis of Venous Thromboembolism in Colombia

    May 1, 2018, 00:00

  • Vascular Access-Specific HRQOL Impacts Among Hemodialysis Patients- The Hemodialysis Access-Related QOL (HARQ) Project Focus Group Results

    May 1, 2018, 00:00

  • Hospital Lenght of Stay and Costs In Patients with Acute Myeloid Leukemia- Analysis of US National In-Patient Data for 2015

    May 1, 2018, 00:00

  • Economic Impact of Dengue in Brazil Over 10 Years (2008-2017)

    May 1, 2018, 00:00

  • Physicians’ Perceived Awareness of Patients’ Medications- A Cross-Sectional Survey

    May 1, 2018, 00:00

  • Utilization Evaluation of Antibiotics at Critical Care Setting of a Tertiary Care Hospital

    May 1, 2018, 00:00

  • Risk-Sharing Agreement- A Model For Her2 (+) Breast Cancer Suitable For The Chilean Context

    May 1, 2018, 00:00

  • Alirocumab Possession Among Medicare Advantage Patients

    May 1, 2018, 00:00

  • Assessment of Health Outcomes Based on Patient Activation Level

    May 1, 2018, 00:00

  • Cost-Effectiveness Analysis of Regorafenib and Tas-102 In Refractory Metastatic Colorectal Cancer

    May 1, 2018, 00:00

  • Development of Patient-Reported Outcome Measures for Masseter Prominence

    May 1, 2018, 00:00

  • Costs and Healthcare Resource Utilization Associated with Hospital Admissions of Prostate Cancer Patients With or without Metastasis

    May 1, 2018, 00:00

  • Treatment Patterns and Costs Associated with Diffuse Large B-Cell Lymphoma—A Retrospective Analysis of Claims

    May 1, 2018, 00:00

  • Consumption of Biologic Treatments for Rheumatoid Arthritis in the Brazilian Public Health System

    May 1, 2018, 00:00

  • Predictive Modelling for Secondary Prevention of Alzheimer’s Disease- Ethical Concerns and Social Implications Based on Targeted, Narrative Literature Review

    May 1, 2018, 00:00

  • Health Behaviors Among Stroke Survivors In The United States- A Propensity Score Matched Study

    May 1, 2018, 00:00

  • Cost-Effectiveness Analysis of Anidulafungin Versus Fluconazole for Invasive Candidiasis in Malaysia

    May 1, 2018, 00:00

  • Harnessing Big Data- A Methodological Approach to Linking Electronic Health Records with Patient-Reported Survey Data

    May 1, 2018, 00:00

  • Biosimilar Regulatory Policies Issues and Implications- Where are we Headed?

    May 1, 2018, 00:00

  • Economic Burden Of Renal Cell Carcinoma Among Older Adults In The Targeted Therapy ERA

    May 1, 2018, 00:00

  • Using Geographic Information System (GIS) to Study the Utilization Trends of Incretin-Based and Peptides Therapies for Type 2 Diabetes in the US Medicaid Programa

    May 1, 2018, 00:00

  • Adherence to Antiretrovirals in Medicaid-Insured Patients Living with HIV- Predictors and Economic Consequences

    May 1, 2018, 00:00

  • Cost-Effectiveness of Cognitive Behavioral Therapy Delivered Via Internet for Children with Functional Abdominal Pain Disorders- Evaluation Alongside A Randomized Controlled Trial

    May 1, 2018, 00:00

  • Global Burden of Seasonal Influenza Disease- A Structured Literature Review

    May 1, 2018, 00:00

  • Systematic Literature Review of Real-World Evidence on Adherence with Biologics in Inflammatory Bowel Disease in the United States

    May 1, 2018, 00:00

  • A Prediction Model for Length of Stay in the Icu Among Septic Patients- A Machine Learning Approach

    May 1, 2018, 00:00
  • «
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60 (current)
  • »